3D bioprinting revolutionizes medicine

Treviso, February 11, 2025 – Biofabrication is transforming the medical field, opening up new possibilities in surgical planning and personalized treatments. A concrete example of this revolution comes from the 3D Innovation Lab at Humanitas, where researchers have successfully reproduced human organs affected by diseases, thanks to the integration of advanced technologies in clinical and research laboratories.
Among the key solutions driving this innovation is Electrospider, the biofabrication system developed by Bio3DPrinting. Already adopted by Humanitas, this technology is proving to be a benchmark in medical research and personalized medicine.
Bio3DPrinting continues to invest in cutting-edge solutions to support the biomedical sector, contributing to the advancement of surgery and biomedical technologies.
Learn more in the RaiNews feature.
Request an appointment, fill out the form:
Related posts

Electrospider and the future of 3D bioprinting at 3DEXPERIENCE WORLD 2025
3D bioprinting opens new frontiers in regenerative medicine: the Electrospider case at 3DEXPERIENCE WORLD 2025

Electrospider Workshop: an immersion in the multi-scale and multi-material bioprinting ecosystem
A high-level meeting to explore the potential of bioprinting in research laboratories.

SolidWorld Group: the Electrospider bioprinter shipped to a prestigious Swiss hospital
The worldwide distribution of the first three-dimensional personalized regenerative medicine platform for oncology research and the creation of implantable human tissues continues.